SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-207470
Filing Date
2023-08-09
Accepted
2023-08-09 17:04:43
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d544313ds3.htm S-3 290931
2 EX-4.5 d544313dex45.htm EX-4.5 287192
3 EX-5.1 d544313dex51.htm EX-5.1 25360
4 EX-23.2 d544313dex232.htm EX-23.2 1564
5 EX-FILING FEES d544313dexfilingfees.htm EX-FILING FEES 45727
6 GRAPHIC g544313g0809023349181.jpg GRAPHIC 1826
7 GRAPHIC g544313g54p03.jpg GRAPHIC 62483
  Complete submission text file 0001193125-23-207470.txt   740870
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-273845 | Film No.: 231156148
SIC: 2836 Biological Products, (No Diagnostic Substances)